QGEN Stock Might Rise Following Partnership With Genomics England

QIAGEN N.V. (QGEN) recently partnered with Genomics England to support the delivery of the Generation Study. QIAGEN’s Clinical Knowledge Base will power a first-of-its-kind whole-genome sequencing study for 100,000 newborns to screen over 200 selected conditions, enabling earlier diagnosis and treatment of rare conditions.The latest partnership aims to broaden the utilization of QIAGEN’s Genomics portfolio.Likely Trend of QGEN Stock Following the NewsFollowing the announcement, shares of the company remaine ...